Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART)

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 102, Issue 3, 2006, Pages 318-324

  Lin, Alan L ^a   Johnson, Dorthea A ^a   Sims, Carol Ann ^a   Stephan, Kevin T ^b   Yeh, Chih Ko ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALIVA PROTEIN; URIC ACID;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CASE CONTROL STUDY; CHEMISTRY; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MUCOSAL IMMUNITY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; SALIVA; SECRETION;

ADULT; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDA ALBICANS; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; HIV INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; MALE; SALIVA; SALIVARY PROTEINS; SECRETORY RATE; STATISTICS, NONPARAMETRIC; URIC ACID;

EID: 33747648537     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.07.021     Document Type: Article

References (33)

1. Dupont B., Crewe Brown H.H., Westermann K., Martins M.D., Rex J.H., Lortholary O., et al. Mycoses in AIDS. Med Mycol 38 Suppl 1 (2000) 259-267
2. Cauda R., Tacconelli E., Tumbarello M., Morace G., De Bernardis F., Torosantucci A., et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection. a prospective case-control study. J Acquir Immune Defic Syndr 21 (1999) 20-25
3. Munro C.A., and Hube B. Anti-fungal therapy at the HAART of viral therapy. Trend Microbiol 10 (2002) 173-177
4. Tappuni A.R., and Fleming G.J. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients. a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 623-628
5. Phelan J.A., Saltzman B.R., Friedland G.H., and Klein R.S. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 64 (1987) 50-56
6. McCarthy G.M. Host factors associated with HIV-related oral candidiasis. Oral Surg Oral Med Oral Pathol 73 (1992) 181-186
7. De Bernardis F., Arancia S., Morelli L., Hube B., Sanglard D., Schafer W., et al. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis 179 (1999) 201-208
8. Cassone A., De Bernardis F., Torosantucci A., Tacconelli E., Tumbarello M., and Cauda R. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180 (1999) 448-453
9. Gottfredsson M., Cox G.M., Indridason Ó.S., de Almeida G.M.D., Heald A.E., and Perfect J.R. Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization. J Infect Dis 180 (1999) 534-537
10. Michelet C., Arvieux C., Francois C., Besnier J.M., Rogez J.P., Breux J.P., et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 12 (1998) 1815-1822
11. Lin A.L., Johnson D.A., Patterson T.F., Wu Y., Lu D., Shi Q., et al. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol 16 (2001) 270-278
12. Yeh C.-K., Fox P.C., Ship J.A., Busch K.A., Bermudez D.K., Wilder A.-M., et al. Oral defense mechanisms are impaired early in HIV-1 infected patients. J Acquir Immune Defic Syndr 1 (1988) 361-366
13. Mandel I.D., Barr C.E., and Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21 (1992) 209-213
14. Coogan M.M., Sweet S.P., and Challacombe S.J. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62 (1994) 892-896
15. Pollock J.J., Santarpia III R.P., Heller H.M., Xu L., Lal K., Fuhrer J., et al. Determination of salivary anticandidal activities in healthy adults and patients with AIDS. a pilot study. J Acquir Immune Defic Syndr 5 (1992) 610-618
16. Lin A.L., Shi Q., Johnson D.A., Patterson T.F., Rinaldi M.G., and Yeh C.-K. Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays. Clin Diagn Lab Immunol 6 (1999) 851-855
17. Lin A.L., Johnson D.A., Stephan K.T., and Yeh C.K. Alteration in salivary function in early HIV infection. J Dent Res 82 (2003) 719-724
18. Lin A.L., Johnson D.A., Stephan K.T., and Yeh C.K. Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med 33 (2004) 410-416
19. Blatt S.P., McCarthy W.F., Bucko-Krasnicka B., Melcher G.P., Boswell R.N., Dolan J., et al. Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis 171 (1995) 837-844
20. Yeh C.-K., Johnson D.A., and Dodds M.W.J. Impact of aging on human salivary gland function. a community-based study. Aging Clin Exp Res 10 (1998) 421-428
21. Shannon I.L., Suddick R.P., and Dowd Jr. F.J. Saliva. composition and secretion. Monogr Oral Sci 2 (1974) 1-103
22. Henskens Y.M., van der Velden U., Veerman E.C., and Nieuw Amerongen A.V. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J Periodont Res 28 (1993) 43-48
23. Porter S.R., and Scully C. Protease inhibitor therapy and oral health care. Oral Dis 4 (1998) 159-163
24. Navazesh M., Mulligan R., Barron Y., Redford M., Greenspan D., Alves M., et al. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 693-698
25. Tylenda C.A., Larsen J., Yeh C.-K., Lane H.C., and Fox P.C. High levels of oral yeasts in early HIV-1 infection. J Oral Pathol Med 18 (1989) 520-524
26. Muzyka B.C. Oral fungal infections. Dent Clin North Am 49 (2005) 49-65 viii
27. Arribas J.R., Hern'ndez-Albujar S., Gonz'lez-García J.J., Peña J.M., Gonzalez A., Cañedo T., et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 14 (2000) 979-985
28. Campisi G., Pizzo G., Milici M.E., Mancuso S., and Margiotta V. Candidal carriage in the oral cavity of human immunodeficiency virus-infected subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 281-286
29. Kondakova I., Lissi E.A., and Pizarro M. Total reactive antioxidant potential in human saliva of smokers and non-smokers. Biochem Mol Biol Int 47 (1999) 911-920
30. Moore S., Calder K.A., Miller N.J., and Rice-Evans C.A. Antioxidant activity of saliva and periodontal disease. Free Radic Res 21 (1994) 417-425
31. Maesaka J.K., Cusano A.J., Thies H.L., Siegal F.P., and Dreisbach A.W. Hypouricemia in aquired immunodeficiency syndrome. Am J Kidney Dis 15 (1990) 252-257
32. Don B.R. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects. Clin Nephrol 55 (2001) 45-52
33. Chertow G.M., Seifter J.L., Christiansen C.L., and O'Donnell W.J. Trimethoprim-sulfamethoxazole and hypouricemia. Clin Nephrol 46 (1996) 193-198